Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by Putting Rubric Principal and Second New Director on the Board

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522356/0/en/Mereo-BioPharma-Offered-to-Settle-Proxy-Contest-with-Rubric-Capital-Management-by-Putting-Rubric-Principal-and-Second-New-Director-on-the-Board.html

Rubric Summarily Rejected the Proposal and Refused to Provide a Counteroffer

Rubric’s Second General Meeting Requisition Notice Again Fails to Satisfy Basic Requirements
of the Companies Act 2006 Which Apply to All U.K. Companies and Shareholders

Read more at globenewswire.com

Related news for (MREO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.